
Low-Dose Chlorthalidone Granted FDA Approval for Treatment of Adults With Hypertension
The FDA has granted regulatory approval to 12.5-mg chlorthalidone (HemiClor; PRM Pharma, LLC) tablets, indicated for the lowering of blood pressure in adults with hypertension, according to a news release by PRM Pharma. This novel, low-dose option joins 25 …